First Trust Advisors
CRMD icon

First Trust Advisors’s CorMedix CRMD Stock Holding History

First Trust Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
48,346
+22,528
+87% +$178K ﹤0.01% 2472
2026
Q1 		$175K Sell
25,818
-4,293
-14% -$31.7K ﹤0.01% 2557
2025
Q4 		$350K Buy
30,111
+15,585
+107% +$172K ﹤0.01% 2418
2025
Q3 		$169K Buy
14,526
+2,969
+26% +$35.9K ﹤0.01% 2522
2025
Q2 		$142K Buy
+11,557
New +$128K ﹤0.01% 2553

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

First Trust Advisors's CRMD Position: Q2 2026 in Review

First Trust Advisors increased its CorMedix (CRMD) stake by 87% in Q2 2026, buying an estimated $178K and bringing the position to 48,346 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

First Trust Advisors first reported a position in CRMD in Q2 2025 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • First Trust Advisors held 48,346 shares of CorMedix worth $380K as of Q2 2026.
  • First Trust Advisors bought 22,528 CorMedix shares in Q2 2026, an estimated $178K.
  • CorMedix made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2472 holding.
  • First Trust Advisors first reported a position in CorMedix in Q2 2025 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.